[A five year follow-up study of antituberculosis chemotherapy with and without rifampicin (author's transl)].
D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D012293:Rifampin / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D012293:Rifampin